AI assistant
GlaxoSmithKline PLC — Director's Dealing 2017
Oct 16, 2017
5262_dirs_2017-10-16_4cbee499-8bf3-44f7-a445-ee12f3d4f3ad.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 7388T
GlaxoSmithKline PLC
16 October 2017
GlaxoSmithKline plc (the 'Company')
Transaction notification
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Ms E Walmsley
b)
Position/status
Chief Executive Officer
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
b)
Nature of the transaction
Increase in notional interest in Ordinary Shares following the re-investment of dividends paid to shareholders on 12 October 2017 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan.
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £15.275 | 75.595 (personal contribution) |
| £15.275 | 187.204 (personal contribution) |
| £15.275 | 203.821 (personal contribution) |
| £15.275 | 75.595 (personal contribution) |
| £15.275 | 187.191 (personal contribution) |
| £15.275 | 203.809 (personal contribution) |
| £15.275 | 75.595 (matching shares) |
| £15.275 | 187.204 (matching shares) |
| £15.275 | 203.821 (matching shares) |
| £15.275 | 75.595 (matching shares) |
| £15.275 | 187.191 (matching shares) |
| £15.275 | 203.809 (matching shares) |
d)
Aggregated information
Aggregated volume Price
1,866.43
£15.275
e)
Date of the transaction
2017-10-12
f)
Place of the transaction
n/a
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Mr R G Connor
b)
Position/status
President, Global Manufacturing & Supply
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
b)
Nature of the transaction
Increase in notional interest in Ordinary Shares following the re-investment of dividends paid to shareholders on 12 October 2017 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan.
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £15.275 | 55.361 (personal contribution) |
| £15.275 | 127.190 (personal contribution) |
| £15.275 | 106.128 (personal contribution) |
| £15.275 | 55.361 (personal contribution) |
| £15.275 | 106.115 (personal contribution) |
| £15.275 | 55.361 (matching shares) |
| £15.275 | 127.19 (matching shares) |
| £15.275 | 106.128 (matching shares) |
| £15.275 | 55.361 (matching shares) |
| £15.275 | 106.115 (matching contribution) |
d)
Aggregated information
Aggregated volume Price
900.310
£15.275
e)
Date of the transaction
2017-10-12
f)
Place of the transaction
n/a
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Mr L Debruyne
b)
Position/status
President, Global Vaccines
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
b)
Nature of the transaction
Increase in notional interest in Ordinary Shares following the re-investment of dividends paid to shareholders on 12 October2017 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan.
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £15.275 | 178.377 (personal contribution) |
| £15.275 | 178.365 (personal contribution) |
| £15.275 | 178.377 (matching shares) |
| £15.275 | 178.365 (matching shares) |
d)
Aggregated information
Aggregated volume Price
713.484
£15.275
e)
Date of the transaction
2017-10-12
f)
Place of the transaction
n/a
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Mr S Dingemans
b)
Position/status
Chief Financial Officer
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
b)
Nature of the transaction
Increase in notional interest in Ordinary Shares following the re-investment of dividends paid to shareholders on 12 October 2017 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan.
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £15.275 | 105.590 (personal contribution) |
| £15.275 | 247.218 (personal contribution) |
| £15.275 | 185.166 (personal contribution) |
| £15.275 | 105.576 (personal contribution) |
| £15.275 | 247.205 (personal contribution) |
| £15.275 | 185.166 (personal contribution) |
| £15.275 | 105.590 (matching shares) |
| £15.275 | 247.218 (matching shares) |
| £15.275 | 185.166 (matching shares) |
| £15.275 | 105.576 (matching shares) |
| £15.275 | 247.205 (matching shares) |
| £15.275 | 185.166 (matching shares) |
d)
Aggregated information
Aggregated volume Price
2,151.842
£15.275
e)
Date of the transaction
2017-10-12
f)
Place of the transaction
n/a
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Mr N Hirons
b)
Position/status
SVP, Global Ethics & Compliance
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
b)
Nature of the transaction
Increase in notional interest in Ordinary Shares following the re-investment of dividends paid to shareholders on 12 October2017 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan.
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £15.275 | 38.762 (personal contribution) |
| £15.275 | 91.407 (personal contribution) |
| £15.275 | 67.081 (personal contribution) |
| £15.275 | 38.762 (personal contribution) |
| £15.275 | 91.407 (personal contribution) |
| £15.275 | 67.068 (personal contribution) |
| £15.275 | 38.762 (matching shares) |
| £15.275 | 91.407 (matching shares) |
| £15.275 | 67.081 (matching shares) |
| £15.275 | 38.762 (matching shares) |
| £15.275 | 91.407 (matching shares) |
| £15.275 | 67.068 (matching shares) |
d)
Aggregated information
Aggregated volume Price
788.974
£15.275
e)
Date of the transaction
2017-10-12
f)
Place of the transaction
n/a
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Mr B McNamara
b)
Position/status
CEO, GSK Consumer Healthcare
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
American Depositary Shares ('ADSs')
ISIN: US37733W1053
b)
Nature of the transaction
Increase in notional interest in ADSs following the re-investment of dividends paid to shareholders on 12 October 2017 on ADSs held in the Company's 2009 Deferred Annual Bonus Plan.
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| $41.020 | 75.963 (personal contribution) |
| $41.020 | 75.963 (matching shares) |
d)
Aggregated information
Aggregated volume Price
151.926
$41.020
e)
Date of the transaction
2017-10-12
f)
Place of the transaction
n/a
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Mr D S Redfern
b)
Position/status
Chief Strategy Officer
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
b)
Nature of the transaction
Increase in notional interest in Ordinary Shares following the re-investment of dividends paid to shareholders on 12 October 2017 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan.
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £15.275 | 62.115 (personal contribution) |
| £15.275 | 116.331 (personal contribution) |
| £15.275 | 84.422 (personal contribution) |
| £15.275 | 62.115 (personal contribution) |
| £15.275 | 116.331 (personal contribution) |
| £15.275 | 84.409 (personal contribution) |
| £15.275 | 62.115 (matching shares) |
| £15.275 | 116.331 (matching shares) |
| £15.275 | 84.422 (matching shares) |
| £15.275 | 62.115 (matching shares) |
| £15.275 | 116.331 (matching shares) |
| £15.275 | 84.409 (matching shares) |
d)
Aggregated information
Aggregated volume Price
1,051.446
£15.275
e)
Date of the transaction
2017-10-12
f)
Place of the transaction
n/a
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Ms C Thomas
b)
Position/status
SVP, Human Resources
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
b)
Nature of the transaction
Increase in notional interest in Ordinary Shares following the re-investment of dividends paid to shareholders on 12 October 2017 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan.
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £15.275 | 83.607 (personal contribution) |
| £15.275 | 170.189 (personal contribution) |
| £15.275 | 127.067 (personal contribution) |
| £15.275 | 83.594 (personal contribution) |
| £15.275 | 170.189 (personal contribution) |
| £15.275 | 127.067 (personal contribution) |
| £15.275 | 83.607 (matching shares) |
| £15.275 | 170.189 (matching shares) |
| £15.275 | 127.067 (matching shares) |
| £15.275 | 83.594 (matching shares) |
| £15.275 | 170.189 (matching shares) |
| £15.275 | 127.067 (matching shares) |
d)
Aggregated information
Aggregated volume Price
1,523.426
£15.275
e)
Date of the transaction
2017-10-12
f)
Place of the transaction
n/a
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Mr P C Thomson
b)
Position/status
President, Global Affairs
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
b)
Nature of the transaction
Increase in notional interest in Ordinary Shares following the re-investment of dividends paid to shareholders on 12 October 2017 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan.
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £15.275 | 56.787 (personal contribution) |
| £15.275 | 104.127 (personal contribution) |
| £15.275 | 79.994 (personal contribution) |
| £15.275 | 56.787 (matching shares) |
| £15.275 | 104.127 (matching shares) |
| £15.275 | 79.994 (matching shares) |
d)
Aggregated information
Aggregated volume Price
481.816
£15.275
e)
Date of the transaction
2017-10-12
f)
Place of the transaction
n/a
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Mr D E Troy
b)
Position/status
SVP & General Counsel
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
American Depositary Shares ('ADSs')
ISIN: US37733W1053
b)
Nature of the transaction
Increase in notional interest in ADSs following the re-investment of dividends paid to shareholders on 12 October 2017 on ADSs held in the Company's 2009 Deferred Annual Bonus Plan.
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| $41.020 | 43.227 (personal contribution) |
| $41.020 | 97.329 (personal contribution) |
| $41.020 | 80.611 (personal contribution) |
| $41.020 | 43.227 (personal contribution) |
| $41.020 | 97.329 (personal contribution) |
| $41.020 | 80.599 (personal contribution) |
| $41.020 | 43.227 (matching shares) |
| $41.020 | 97.329 (matching shares) |
| $41.020 | 80.611 (matching shares) |
| $41.020 | 43.227 (matching shares) |
| $41.020 | 97.329 (matching shares) |
| $41.020 | 80.599 (matching shares) |
d)
Aggregated information
Aggregated volume Price
884.644
$41.020
e)
Date of the transaction
2017-10-12
f)
Place of the transaction
n/a
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Dr P J T Vallance
b)
Position/status
President, R&D
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
b)
Nature of the transaction
Increase in notional interest in Ordinary Shares following the re-investment of dividends paid to shareholders on 12 October 2017 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan.
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £15.275 | 123.070 (personal contribution) |
| £15.275 | 200.197 (personal contribution) |
| £15.275 | 138.016 (personal contribution) |
| £15.275 | 123.070 (personal contribution) |
| £15.275 | 200.197 (personal contribution) |
| £15.275 | 138.016 (personal contribution) |
| £15.275 | 123.070 (matching shares) |
| £15.275 | 200.197 (matching shares) |
| £15.275 | 138.016 (matching shares) |
| £15.275 | 123.070 (matching shares) |
| £15.275 | 200.197 (matching shares) |
| £15.275 | 138.016 (matching shares) |
d)
Aggregated information
Aggregated volume Price
1,845.132
£15.275
e)
Date of the transaction
2017-10-12
f)
Place of the transaction
n/a
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHEQLFFDBFEFBF